Elevation Oncology (ELEV) News Today $0.28 -0.01 (-3.48%) As of 12:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Stephens & Co. Downgrades Elevation Oncology (ELEV)March 25 at 8:26 AM | msn.comAnalysts Issue Forecasts for ELEV FY2029 EarningsMarch 25 at 2:39 AM | americanbankingnews.comElevation Oncology downgraded to Equal Weight from Overweight at StephensMarch 24 at 3:03 PM | markets.businessinsider.comElevation Oncology, Inc. (NASDAQ:ELEV) Receives $6.83 Average Target Price from AnalystsMarch 24 at 4:39 AM | americanbankingnews.comElevation Oncology (NASDAQ:ELEV) Lowered to Market Perform Rating by Leerink PartnersMarch 24 at 2:35 AM | americanbankingnews.comElevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by Piper SandlerMarch 24 at 2:35 AM | americanbankingnews.comHC Wainwright Cuts Elevation Oncology (NASDAQ:ELEV) Price Target to $1.00March 24 at 1:49 AM | americanbankingnews.comElevation Oncology (NASDAQ:ELEV) Lowered to "Market Perform" Rating by Citizens JmpMarch 23 at 3:21 AM | americanbankingnews.comElevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by WedbushMarch 23 at 1:39 AM | americanbankingnews.comCitizens Capital Markets Downgrades Elevation Oncology (ELEV)March 22 at 2:40 AM | msn.comLeerink Partners Downgrades Elevation Oncology (ELEV)March 21, 2025 | msn.comElevation Oncology downgraded to Market Perform from Outperform at Citizens JMPMarch 21, 2025 | markets.businessinsider.comElevation Oncology price target lowered to $1 from $6 at H.C. WainwrightMarch 21, 2025 | markets.businessinsider.comElevation Oncology (NASDAQ:ELEV) Stock, Short Interest ReportMarch 21, 2025 | benzinga.comElevation Oncology downgraded as it halts lead asset on disappointing trialsMarch 21, 2025 | investing.comElevation Oncology to discontinue development of EO-3021; Advancing EO-1022March 21, 2025 | markets.businessinsider.comElevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70%March 20, 2025 | benzinga.comElevation Oncology stock tumbles on halted drug developmentMarch 20, 2025 | ca.investing.comElevation Oncology slumps on plans to drop cancer candidateMarch 20, 2025 | msn.comElevation Oncology Shares Halt on Layoffs, Discontinued Drug CandidateMarch 20, 2025 | marketwatch.comElevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic OptionsMarch 20, 2025 | prnewswire.comElevation Oncology’s Future in Jeopardy: Financing Challenges Threaten Product DevelopmentMarch 8, 2025 | tipranks.comElevation Oncology Reports 2024 Financial Results and ProgressMarch 7, 2025 | tipranks.comElevation Oncology reports Q4 EPS (18c), consensus (22c)March 7, 2025 | markets.businessinsider.comElevation Oncology sees current cash and equivalents sufficient into 2026March 7, 2025 | markets.businessinsider.comElevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business AchievementsMarch 6, 2025 | prnewswire.comMOC Cancer Care raises $18 million from Elevation CapitalFebruary 26, 2025 | msn.comElevation Oncology to Participate in Upcoming Investor ConferencesFebruary 25, 2025 | prnewswire.comElevation Oncology announces CSO departureFebruary 3, 2025 | msn.comElevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming MilestonesJanuary 13, 2025 | prnewswire.comWilliam Blair Initiates Coverage of Elevation Oncology (ELEV) with Outperform RecommendationJanuary 4, 2025 | msn.comElevation Oncology initiated with an Outperform at William BlairJanuary 3, 2025 | msn.comSynaffix B.V.: Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionDecember 12, 2024 | finanznachrichten.deElevation Oncology enters licensing agreement with Synaffix B.V.December 12, 2024 | markets.businessinsider.comElevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionDecember 12, 2024 | prnewswire.comElevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid TumorsDecember 12, 2024 | prnewswire.comElevation Oncology presents positive Phase 1 results of EO-3021 combinationDecember 6, 2024 | markets.businessinsider.comElevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024December 5, 2024 | prnewswire.comElevation Oncology to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 26, 2024 | prnewswire.comTD Cowen Sticks to Its Buy Rating for Elevation Oncology (ELEV)November 8, 2024 | markets.businessinsider.comElevation Oncology’s Q3 2024 Highlights and Financial ReportNovember 8, 2024 | markets.businessinsider.comElevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business AchievementsNovember 6, 2024 | prnewswire.comEmpery Asset Management's Strategic Acquisition in Elevation OncologyOctober 9, 2024 | gurufocus.comElevation Oncology Gets FDA Fast-Track Designation for EO-3021September 24, 2024 | marketwatch.comElevation Oncology Receives Fast Track Designation For EO-3021 - Quick FactsSeptember 24, 2024 | markets.businessinsider.comElevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2September 23, 2024 | prnewswire.comElevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | prnewswire.comElevation Oncology, Inc. (ELEV)August 16, 2024 | finance.yahoo.comInfinyte.Club, HealthCRED, and MiClient Raise Seed FundingAugust 13, 2024 | msn.comElevation Oncology’s EO-3021 Shows Promising Efficacy and Safety in Gastric Cancer, Outperforming Market ExpectationsAugust 7, 2024 | markets.businessinsider.com Remove Ads Get Elevation Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ELEV and its competitors with MarketBeat's FREE daily newsletter. Email Address ELEV Media Mentions By Week ELEV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELEV News Sentiment▼-0.470.63▲Average Medical News Sentiment ELEV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELEV Articles This Week▼311▲ELEV Articles Average Week Remove Ads Get Elevation Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ELEV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TELO News RENB News VIRI News EDIT News ADAP News SLN News SGMT News COYA News NKTX News DERM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELEV) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELEV Stock Free ELEV Stock Alerts